Programme Category
Programme Name
Programme Description
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3) builds on the first and second European and Developing Countries Clinical Trials Partnership programmes. This new joint undertaking (JU) is a partnership between the EU and the EDCTP Association, whose members are several European and African countries. The partnership will deliver new solutions for reducing the burden of infectious diseases in SSA and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
Identifier Code
Call
Summary
Proposals submitted to this topic should implement a master’s level training programme in a discipline relevant for the Global Health EDCTP3 JU, providing transferable R&D skills, fostering innovation and entrepreneurship, incl. commercialisation of results, Intellectual Property Rights, communication, public engagement, and citizen science. The training provided by the academic institutions is expected to be complemented by training modules provided by pharmaceutical companies. It is expected that pharmaceutical companies will join the consortium as beneficiaries and/or associated partners at a later stage. The companies are expected to bring cash or in-kind contributions to the training programme for the fellows.
The training will address the research and development value chain from pre-clinical to clinical research including pharmaceuticals and vaccines.
Detailed Call Description
Proposals must demonstrate all of the following:
- A high-quality training programme related to R&D on diseases in the scope of the Global Health EDCTP3 JU at master level in global health/clinical research;
- An open, fair and transparent procedure for selecting the fellows coming from different geographical regions of SSA, based on quality and with appropriate gender balance;
- Design of a programme where training for each fellow includes a first phase (or outgoing phase) of minimum 12 and maximum 24 months enrolment into an academic organization, and a second phase (or return phase) of at least 12 months in the country of origin of the fellow;
- A robust training and mentorship mechanisms to support the fellows through their first training phase and second home return phase;
- Linkages with other Global Health EDCTP3 JU actions should be foreseen as relevant (e.g. Global Health EDCTP3 Training Networks or Global Health EDCTP3 Genomic Epidemiology Networks).
Proposals should be made by institutions with a proven track record in the provision of high-quality research training and established regional and global collaborations. These may include research organisations, institutions of higher learning such as universities.
The proposals must explain how many fellows they plan to recruit, what the cost of the training in the first phase will be and how much funding will be provided to the fellows for the return phase.
Based on the described skills and curricula offered by the successful consortium, future fellows will apply to the available training opportunities in line with their own professional development plans.
Proposals should also clearly outline how future fellows will be mentored in the development and implementation of the second phase (return phase) at the home institution in SSA.
In-kind and financial contributions from private (profit and non-profit) entities, clinical research organisations and others interested in this scheme are encouraged. Financial contributions can be made with or without direct participation in the project implementation.
Especially, consortium members established in countries that are not eligible for the Global Health EDCTP3 JU funding, will have to cover the costs related to their tasks within the project without JU funding.
Financial contributions from third parties (e.g., foundations) interested in this scheme are encouraged to contribute to increase the budget, diversity, and impact.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Expected EU Contribution per project: €3.5 M
Beneficiaries may provide financial support to third parties. The maximum amount to be granted to each third party is €300.000. The support to third parties can only be provided in the form of grants. These grants are the fellowships to be awarded. For multi-annual fellowships, the amount of up to €300.000 is needed.
Thematic Categories
- Education and training
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Educational Institutions
- Large Enterprises
- Legal Entities
- Other Beneficiaries
- Researchers/Research Centers/Institutions
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
- Training Centres
Eligibility For Participation Notes
To become a beneficiary, legal entities must be eligible for funding.
To be eligible for funding, applicants must be established in one of the following countries:
- The Member States of the European Union, including their outermost regions: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden;
- The Overseas Countries and Territories (OCTs) linked to the Member States: Aruba (NL), Bonaire (NL), Curação (NL), French Polynesia (FR), French Southern and Antarctic Territories (FR), Greenland (DK), New Caledonia (FR), Saba (NL), Saint Barthélemy (FR), Sint Eustatius (NL), Sint Maarten (NL), St. Pierre and Miquelon (FR), Wallis and Futuna Islands (FR);
- Countries associated to Horizon Europe : Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand (associated to Pillar II ‘Global Challenges and European Industrial Competitiveness’ as from the Work Programmes 2023 onwards, including for the institutionalised European partnerships), North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine.
Until association agreements start producing legal effects either through provisional application or their entry into force, transitional arrangements apply. The transitional arrangements apply, at the time of the adoption of this Work Programme, with regard to the following countries and legal entities established in these countries, with which association negotiations are being processed or where association is imminent):
1. Canada
2. Morocco
- The following countries which are constituent states of the EDCTP Association: Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea-Bissau, Guinea-Conakry, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Tanzania, Uganda, Zambia, Zimbabwe.
Consortium composition
Unless otherwise provided for in the specific call conditions, for all actions, due to the policy objectives of the Global Health EDCTP3 JU, legal entities forming a consortium are eligible to participate in actions under the programme provided that the consortium includes:
- At least three legal entities independent from each other and established in different countries, where legal entities are eligible to receive funding;
- At least one independent legal entity established in a Member State or an associated country; and
- At least one independent legal entity established in a sub-Saharan African (SSA) country that is a member of the EDCTP Association.
This condition applies to both Research and Innovation Actions (RIA) and Coordination and Support Actions (CSA).
Specific cases:
Affiliated entities — Affiliated entities (i.e. entities with a legal or capital link to a beneficiary[4] which participate in the action with similar rights and obligations to the beneficiaries, but which do not sign the grant agreement and therefore do not become beneficiaries themselves) are allowed, if they are eligible for participation and funding.
Associated partners — Entities not eligible for funding (and therefore not able to participate as beneficiaries) may participate as associated partners, unless specified otherwise in the specific call conditions.
International organisations – International European research organisations are eligible to receive funding. Other international organisations are not eligible to receive funding unless their participation is considered essential for implementing the action by the granting authority. International organisations with headquarters in a Member State or associated country are eligible to receive funding when provided for in the specific call conditions.
Call Opening Date
Call Closing Date
EU Contact Point
EDCTP – Europe Office
Postal and visiting address: Anna van Saksenlaan 51, 2593 HW The Hague, The Netherlands
Telephone: +31 70 344 0880
EDCTP – Africa Office
Postal address: P.O. Box 19070, Tygerberg 7505, Cape Town, South Africa
Visiting address: Francie van Zijl Drive, Parowvallei 7505, Cape Town, South Africa
Telephone: +27 21 938 0690
Fax: +27 21 938 0569
Contact Form in the website